D. Maroeska W. M. te Loo

2.4k total citations
73 papers, 1.5k citations indexed

About

D. Maroeska W. M. te Loo is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, D. Maroeska W. M. te Loo has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Hematology. Recurrent topics in D. Maroeska W. M. te Loo's work include Acute Lymphoblastic Leukemia research (13 papers), Vascular Malformations and Hemangiomas (11 papers) and Escherichia coli research studies (10 papers). D. Maroeska W. M. te Loo is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Vascular Malformations and Hemangiomas (11 papers) and Escherichia coli research studies (10 papers). D. Maroeska W. M. te Loo collaborates with scholars based in Netherlands, United States and Belgium. D. Maroeska W. M. te Loo's co-authors include L.A.H. Monnens, Lambertus P. van den Heuvel, Victor W.M. van Hinsbergh, Marieke J. H. Coenen, Melanie M. Hagleitner, Henk‐Jan Guchelaar, Thea J. A. M. van der Velden, Uta Flucke, Eveline S.J.M. de Bont and Winette T.A. van der Graaf and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

D. Maroeska W. M. te Loo

71 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Maroeska W. M. te Loo Netherlands 22 336 318 310 297 297 73 1.5k
Roberto Conte Italy 25 69 0.2× 69 0.2× 504 1.6× 684 2.3× 106 0.4× 81 2.1k
VW van Hinsbergh Netherlands 14 373 1.1× 28 0.1× 437 1.4× 325 1.1× 29 0.1× 22 1.8k
Camille Hua France 18 16 0.0× 281 0.9× 745 2.4× 171 0.6× 94 0.3× 43 1.7k
Hoon Kook South Korea 22 13 0.0× 139 0.4× 546 1.8× 559 1.9× 86 0.3× 131 1.8k
Peter Meyer Germany 20 27 0.1× 94 0.3× 112 0.4× 430 1.4× 21 0.1× 51 1.8k
Hirobumi Kondo Japan 25 46 0.1× 106 0.3× 404 1.3× 348 1.2× 9 0.0× 85 1.7k
Philip Seu United States 25 19 0.1× 248 0.8× 186 0.6× 292 1.0× 52 0.2× 49 2.5k
John P. Whitecar United States 13 24 0.1× 271 0.9× 115 0.4× 168 0.6× 121 0.4× 18 977
S. Cohney Australia 23 13 0.0× 207 0.7× 716 2.3× 225 0.8× 53 0.2× 40 2.0k
Robert L. Young United States 20 34 0.1× 95 0.3× 283 0.9× 377 1.3× 32 0.1× 34 2.2k

Countries citing papers authored by D. Maroeska W. M. te Loo

Since Specialization
Citations

This map shows the geographic impact of D. Maroeska W. M. te Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Maroeska W. M. te Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Maroeska W. M. te Loo more than expected).

Fields of papers citing papers by D. Maroeska W. M. te Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Maroeska W. M. te Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Maroeska W. M. te Loo. The network helps show where D. Maroeska W. M. te Loo may publish in the future.

Co-authorship network of co-authors of D. Maroeska W. M. te Loo

This figure shows the co-authorship network connecting the top 25 collaborators of D. Maroeska W. M. te Loo. A scholar is included among the top collaborators of D. Maroeska W. M. te Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Maroeska W. M. te Loo. D. Maroeska W. M. te Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kievit, Wietske, et al.. (2024). The Economic Consequences of Sirolimus Treatment in Patients With Vascular Malformations. SHILAP Revista de lepidopterología. 5(2). e092–e092. 1 indexed citations
2.
Bouwman, Frederique, Bas H. Verhoeven, C.J.M. van der Vleuten, et al.. (2023). Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus. Frontiers in Medicine. 10. 1155476–1155476. 4 indexed citations
3.
Loo, D. Maroeska W. M. te, et al.. (2023). Influence of Genetic Variants on the Pharmacokinetics and Pharmacodynamics of Sirolimus: A Systematic Review. Pharmacogenomics. 24(11). 629–639. 1 indexed citations
4.
Dompmartin, A., C.J.M. van der Vleuten, Thierry Duprez, et al.. (2022). GNA11‐mutated Sturge–Weber syndrome has distinct neurological and dermatological features. European Journal of Neurology. 29(10). 3061–3070. 22 indexed citations
5.
Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2021). Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response. British Journal of Haematology. 194(2). 423–432. 5 indexed citations
6.
Loo, D. Maroeska W. M. te, et al.. (2020). Aberrant venous anatomy as a risk factor for thromboembolic events in patients with Klippel-Trénaunay syndrome: Case-control study within a cohort study. Journal of the American Academy of Dermatology. 84(5). 1470–1472. 6 indexed citations
7.
Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2019). Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients. Clinical Infectious Diseases. 71(8). e281–e288. 5 indexed citations
8.
Moerloose, Barbara De, Ardine Reedijk, Geertruida H. de Bock, et al.. (2019). Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01. Pediatric Blood & Cancer. 66(5). e27605–e27605. 23 indexed citations
9.
Lauw, Mandy N., Marianne D. van de Wetering, Bart J. Biemond, et al.. (2017). TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial. BMC Pediatrics. 17(1). 122–122. 22 indexed citations
10.
Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2016). Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients. Haematologica. 102(3). 552–561. 16 indexed citations
11.
Guchelaar, Henk‐Jan, Hans Gelderblom, Eveline S.J.M. de Bont, et al.. (2016). Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma. Pharmacogenetics and Genomics. 26(5). 243–247. 42 indexed citations
12.
Tong, Wing H., Rob Pieters, Gertjan J.L. Kaspers, et al.. (2014). A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood. 123(13). 2026–2033. 155 indexed citations
13.
Hagleitner, Melanie M., Marieke J. H. Coenen, Hans Gelderblom, et al.. (2012). Association of the genetic variants in the nucleotide excision repair genes XPA and XPC with cisplatin-induced hearing loss in patients with osteosarcoma.. Journal of Clinical Oncology. 30(15_suppl). 10077–10077. 1 indexed citations
14.
Geelen, Joyce, Thea J. A. M. van der Velden, D. Maroeska W. M. te Loo, et al.. (2006). Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrology Dialysis Transplantation. 22(3). 749–755. 25 indexed citations
15.
Loo, D. Maroeska W. M. te, Willem A. Kamps, Anna Berg, Elisabeth R. van Wering, & Siebold S.N. de Graaf. (2006). Prognostic Significance of Blasts in the Cerebrospinal Fluid Without Pleiocytosis or a Traumatic Lumbar Puncture in Children With Acute Lymphoblastic Leukemia: Experience of the Dutch Childhood Oncology Group. Journal of Clinical Oncology. 24(15). 2332–2336. 69 indexed citations
16.
Loo, D. Maroeska W. M. te, L.A.H. Monnens, Thea J. A. M. van der Velden, et al.. (2006). Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells. Pediatric Nephrology. 21(12). 1815–1823. 12 indexed citations
17.
Fernández, Gabriela, et al.. (2003). Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Pediatric Nephrology. 18(10). 1066–1068. 19 indexed citations
18.
Loo, D. Maroeska W. M. te, L.A.H. Monnens, Lambertus P. van den Heuvel, Marie-Claire Gübler, & Mark Kockx. (2001). Detection of Apoptosis in Kidney Biopsies of Patients with D+ Hemolytic Uremic Syndrome. Pediatric Research. 49(3). 413–416. 12 indexed citations
19.
Heuvelink, Annet, D. Maroeska W. M. te Loo, & L.A.H. Monnens. (2001). [Hemolytic uremic syndrome in children].. PubMed. 145(13). 620–5. 1 indexed citations
20.
Loo, D. Maroeska W. M. te, Annet Heuvelink, Jeroen Nauta, et al.. (2001). Vero Cytotoxin Binding to Polymorphonuclear Leukocytes among Households with Children with Hemolytic Uremic Syndrome. The Journal of Infectious Diseases. 184(4). 446–450. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Conte Breakdown of academic impact, for papers by VW van Hinsbergh Breakdown of academic impact, for papers by Camille Hua Breakdown of academic impact, for papers by Hoon Kook Breakdown of academic impact, for papers by Peter Meyer Breakdown of academic impact, for papers by Hirobumi Kondo Breakdown of academic impact, for papers by Philip Seu Breakdown of academic impact, for papers by John P. Whitecar Breakdown of academic impact, for papers by S. Cohney Breakdown of academic impact, for papers by Robert L. Young
Rankless by CCL
2026